From: Abstracts from the College of Podiatry Annual Conference 2019
Outcome measure (possible score range) | Baseline Count, mean ± SD (min-max) | 12 weeks Count, mean ± SD (min-max) | 24 weeks Count, mean ± SD (min-max) |
MTP joint synovitis (0-10) | 23, 2 ± 3 (0-10) | 17, 2 ± 3 (0-10) | 15, 2 ± 3 (0-10) |
Forefoot bursae (0-18) | 29, 5 ± 4 (0-18) | 20, 3 ± 3 (0-8) | 20, 3 ± 4 (0-15) |
Forefoot bursitis (0-18) | 25, 4 ± 4 (0-18) | 16, 2 ± 3 (0-8) | 16, 3 ± 4 (0-17) |
Tenosynovitis (0-20) | 11, 1 ± 2 (0-8) | 7, 1 ± 1 (0-4) | 4, 0 ± 1 (0-7) |
Foot impairment (0-21) | 15 ± 5 (1-20) | 10 ± 5 (2-20) | 10 ± 5 (1-20) |
Foot related activity limitation (0-30) | 18 ± 9 (0-30) | 14 ± 10 (0-29) | 15 ± 5 10 (0-30) |
Pain (Yes/No) | 27 (82%) | 21 (64%) | 23 (70%) |
DAS 28 (2-10) | 6 ± 1 (4-7) | 4 ± 1 (1-8) | 4 ± 2 (1-8) |